Inari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of ($0.19), $0.06 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $96.2 million versus the consensus estimate of $90.79 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.